Having trouble identifying pills? Try the Pill Identifier

Quickly identify pills, tablets and capsules using the web's most comprehensive Pill Identification Wizard.

Get Started

Worried about drug interactions? Use the Interactions Checker

The drug interactions tool allows you to check for drug-drug and drug-food interactions.

Check Now

Discover treatment options with the new Symptom Checker

This interactive decision guide helps identify the underlying cause of common symptoms.

Get Started

Custom search for Medical Transcriptionists?

Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.

Get Started

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Posted today in New Drug Approvals

FDA Approves Evotaz (atazanavir and cobicistat) for HIV-1 Infection in Adults

January 29, 2015 --(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today that the U.S. Food and Drug Administration (FDA) has approved Evotaz (atazanavir 300 mg and cobicistat 150 mg) tablets in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults. Evotaz is coformulated to be one pill, once-daily,...

Posted today in Medical

More Evidence That Boxing Can Lead to Brain Damage

Another study supports the notion that repeated blows to the head in boxing or the martial arts can damage the brain. The study, led by Dr. Charles Bernick of the Cleveland Clinic, included professional fighters -- 93 boxers and 131 mixed martial arts experts. They ranged in age from 18 to 44, and were compared against 22 people of similar age with...

Posted today in New Drug Approvals

FDA Expands Approved Use of Imbruvica for Waldenström’s Macroglobulinemia

The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) for patients with Waldenström’s macroglobulinemia (WM), a rare form of cancer that begins in the body’s immune system. The drug received a breakthrough therapy designation for this use. A type of non-Hodgkin lymphoma, WM usually gets worse slowly over...

Posted today in Pharma Industry News

Monthly News Roundup - January 2015

Novartis Wins 1st Approval in Race for New Psoriasis Blockbusters The most common form of psoriasis is plaque psoriasis, in which patients develop thick, reddened skin with white patches called scales. The U.S. Food and Drug Administration has approved Cosentyx (secukinumab), a subcutaneous injection to treat adults with moderate-to-severe plaque...

Posted today in Medical

Health Tip: Prepare Your Child for College

-- Before sending your child to college, sure your teen is ready to take charge of his or her own health. The American Academy of Pediatrics suggests: Visit the doctor to ensure your child is up to date on all vaccinations. Find out how to coordinate health care between the doctor at home and the health center at school. Make sure your child knows...

Posted today in Medical

More Measles Cases Seen in January Than in Typical Year: CDC

The United States has seen more cases of measles in January than it usually does in an entire year, federal health officials said Thursday. A total of 84 cases in 14 states were reported between Jan. 1 and Jan. 28, Dr. Anne Schuchat, director of the National Center for Immunization and Respiratory Diseases at the U.S. Centers for Disease Control and...

Posted today in New Drug Approvals

FDA Approves Prezcobix (darunavir and cobicistat) for HIV-1 Infection in Adults

Janssen Therapeutics, Division of Janssen Products, LP (Janssen), today announced the U.S. Food and Drug Administration (FDA) has approved Prezcobix (darunavir 800 mg/cobicistat 150 mg) tablets, an HIV-1 protease inhibitor combined with a CYP3A4 inhibitor, for the treatment of human immunodeficiency virus (HIV-1) in combination with other antiretroviral...

Posted today in Medical

Health Tip: Drink Responsibly

-- Responsible drinking is a surefire way to prevent alcohol abuse and alcohol poisoning, a dangerous complication of drinking too much. The U.S. Centers for Disease Control and Prevention suggests: Don't over-drink or binge drink. Don't mix alcohol with energy drinks. The caffeine in energy drinks may mask the effects of alcohol and lead to drinking...

Posted today in Medical

Colon Cancer Rates Rising Among Americans Under 50

Although the overall rate of colon cancer has fallen in recent decades, new research suggests that over the last 20 years the disease has been increasing among young and early middle-aged American adults. At issue are colon cancer rates among men and women between the ages of 20 and 49, a group that generally isn't covered by public health guidelines. "This...

Posted today in Medical

Tamiflu Cuts One Day Off Average Flu Bout, Study Finds

A review of the data suggests that the antiviral drug Tamiflu shortens the length of flu symptoms by about a day, and reduces the risk of flu-related complications such as pneumonia. The findings come from an analysis of nine published and unpublished randomized clinical trials of Tamiflu (oseltamivir) in adults. The data was provided to the researchers...

Read more news...

Recently added consumer and prescribing information: Xigduo XR, Ofev, Esbriet, Harvoni, Akynzeo, Tybost, Vitekta, Trulicity, Movantik, Contrave

Posted in Blog

Biosimilars in 2015: What Can We Expect?

On Wednesday, January 7th, the FDA Oncologic Drugs Advisory Committee unanimously recommended approval of Sandoz’s EP2006, a biosimilar for filgrastim (Neupogen). EP2006 is a recombinant granulocyte colony-stimulating factor used to boost white blood cells after cancer treatments that deplete these necessary infection-fighting cells. If FDA-approved, this would be the first true biosimilar in the U.S. […]

Posted in Blog

Drugs.com Adds Mayo Clinic Disease Reference

Drugs.com is pleased to announce it has licensed select content from Mayo Clinic to provide more timely and trustworthy medical condition and disease information. The articles include detailed information about medical diseases such as allergies, back pain, depression, erectile dysfunction, and type 2 diabetes. Each article includes informative sections which may include an overview, symptoms, when […]

Posted in Blog

Fox News Features Drugs.com Medication Guide app

Thanks to Fox News for showcasing the Drugs.com Medication Guide app today. Very much appreciated. Available in both the Apple App store and the Google Play store, this is a great app for ultra-quick research and/or keeping track of multiple meds. Check out the video at the link below… http://www.foxnews.com/health/2014/07/13/drugscom-app-provides-medical-information-on-go/ And check out the apps here… http://www.drugs.com/apps/

See more blog posts or follow us on twitter.

Hide
(web4)